Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2008 2
2009 5
2010 3
2011 6
2012 8
2013 15
2014 15
2015 14
2016 17
2017 20
2018 6
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 27856633

96 results
Results by year
Filters applied: . Clear all
Page 1
Effects of Vitamin D Receptor Activation and Dietary Sodium Restriction on Residual Albuminuria in CKD: The ViRTUE-CKD Trial.
Keyzer CA, van Breda GF, Vervloet MG, de Jong MA, Laverman GD, Hemmelder MH, Janssen WM, Lambers Heerspink HJ, Kwakernaak AJ, Bakker SJ, Navis G, de Borst MH; Holland Nephrology Study (HONEST) Network. Keyzer CA, et al. J Am Soc Nephrol. 2017 Apr;28(4):1296-1305. doi: 10.1681/ASN.2016040407. Epub 2016 Nov 17. J Am Soc Nephrol. 2017. PMID: 27856633 Free PMC article. Clinical Trial.
Vitamin D receptor activator and dietary sodium restriction to reduce residual urinary albumin excretion in chronic kidney disease (ViRTUE study): rationale and study protocol.
Keyzer CA, de Jong MA, Fenna van Breda G, Vervloet MG, Laverman GD, Hemmelder M, Janssen WM, Lambers Heerspink HJ, Navis G, de Borst MH; Holland Nephrology Study (HONEST) Network. Keyzer CA, et al. Nephrol Dial Transplant. 2016 Jul;31(7):1081-7. doi: 10.1093/ndt/gfv033. Epub 2015 Mar 4. Nephrol Dial Transplant. 2016. PMID: 25744274 Review.
Moderate salt restriction with or without paricalcitol in type 2 diabetes and losartan-resistant macroalbuminuria (PROCEED): a randomised, double-blind, placebo-controlled, crossover trial.
Parvanova A, Trillini M, Podestà MA, Iliev IP, Ruggiero B, Abbate M, Perna A, Peraro F, Diadei O, Rubis N, Gaspari F, Carrara F, Stucchi N, Belviso A, Bossi AC, Trevisan R, Remuzzi G, de Borst M, Ruggenenti P; PROCEED Study Organization and the Scientific Writing Academy (SWA) 2016. Parvanova A, et al. Lancet Diabetes Endocrinol. 2018 Jan;6(1):27-40. doi: 10.1016/S2213-8587(17)30359-5. Epub 2017 Nov 2. Lancet Diabetes Endocrinol. 2018. PMID: 29104158 Clinical Trial.
Effects of intensive low-salt diet education on albuminuria among nondiabetic patients with hypertension treated with olmesartan: a single-blinded randomized, controlled trial.
Hwang JH, Chin HJ, Kim S, Kim DK, Kim S, Park JH, Shin SJ, Lee SH, Choi BS, Lim CS. Hwang JH, et al. Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2059-69. doi: 10.2215/CJN.01310214. Epub 2014 Oct 20. Clin J Am Soc Nephrol. 2014. PMID: 25332317 Free PMC article. Clinical Trial.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial.
de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D. de Zeeuw D, et al. Lancet. 2010 Nov 6;376(9752):1543-51. doi: 10.1016/S0140-6736(10)61032-X. Lancet. 2010. PMID: 21055801 Clinical Trial.
Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial.
Slagman MC, Waanders F, Hemmelder MH, Woittiez AJ, Janssen WM, Lambers Heerspink HJ, Navis G, Laverman GD; HOlland NEphrology STudy Group. Slagman MC, et al. BMJ. 2011 Jul 26;343:d4366. doi: 10.1136/bmj.d4366. BMJ. 2011. PMID: 21791491 Free PMC article. Clinical Trial.
Effects of Dietary Sodium Restriction in Kidney Transplant Recipients Treated With Renin-Angiotensin-Aldosterone System Blockade: A Randomized Clinical Trial.
de Vries LV, Dobrowolski LC, van den Bosch JJ, Riphagen IJ, Krediet CT, Bemelman FJ, Bakker SJ, Navis G. de Vries LV, et al. Am J Kidney Dis. 2016 Jun;67(6):936-44. doi: 10.1053/j.ajkd.2015.11.026. Epub 2016 Jan 21. Am J Kidney Dis. 2016. PMID: 26803690 Clinical Trial.
Elevated N-terminal pro-brain natriuretic peptide levels predict an enhanced anti-hypertensive and anti-proteinuric benefit of dietary sodium restriction and diuretics, but not angiotensin receptor blockade, in proteinuric renal patients.
Slagman MC, Waanders F, Vogt L, Damman K, Hemmelder M, Navis G, Laverman GD. Slagman MC, et al. Nephrol Dial Transplant. 2012 Mar;27(3):983-90. doi: 10.1093/ndt/gfr408. Epub 2011 Aug 22. Nephrol Dial Transplant. 2012. PMID: 21862455 Clinical Trial.
Sodium restriction potentiates the renoprotective effects of combined vitamin D receptor activation and angiotensin-converting enzyme inhibition in established proteinuric nephropathy.
Mirkovic K, Frenay AS, van den Born J, van Goor H, Navis G, de Borst MH; NIGRAM consortium. Mirkovic K, et al. Nephrol Dial Transplant. 2017 Aug 1;32(8):1293-1301. doi: 10.1093/ndt/gfv304. Nephrol Dial Transplant. 2017. PMID: 26311058
Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: a randomized placebo-controlled trial.
Larsen T, Mose FH, Bech JN, Pedersen EB. Larsen T, et al. BMC Nephrol. 2013 Jul 26;14:163. doi: 10.1186/1471-2369-14-163. BMC Nephrol. 2013. PMID: 23889806 Free PMC article. Clinical Trial.
96 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback